Hasil Pencarian - Junling Zhuang

  • Menampilkan 1 - 20 hasil dari 20
Perbaiki Hasil
  1. 1
    Major advances in the treatment of multiple myeloma in American Society of Hematology annual meeting 2020

    Major advances in the treatment of multiple myeloma in American Society of Hematology annual meeting 2020 oleh Jianhua Du, Junling Zhuang

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Pathophysiology and therapeutic advances in myeloma bone disease

    Pathophysiology and therapeutic advances in myeloma bone disease oleh Fujing Zhang, Junling Zhuang

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Pure red cell aplasia and minimal residual disease conversion associated with immune reconstitution in a patient with high‐risk multiple myeloma

    Pure red cell aplasia and minimal residual disease conversion associated with immune reconstitution in a patient with high‐risk multiple myeloma oleh Xianghong Jin, Xianyong Jiang, Wei Wang, Shuangjiao Liu, Bing Han, Jianhua Han, Junling Zhuang

    Diterbitkan 2023-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Hereditary intrinsic factor deficiency in China caused by a novel mutation in the intrinsic factor gene—a case report

    Hereditary intrinsic factor deficiency in China caused by a novel mutation in the intrinsic factor gene—a case report oleh Jing Ruan, Bing Han, Junling Zhuang, Miao Chen, Fangfei Chen, Yuzhou Huang, Wenzhe Zhou

    Diterbitkan 2020-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    11C-acetate positron emission tomography is more precise than 18F-fluorodeoxyglucose positron emission tomography in evaluating tumor burden and predicting disease risk of multiple myeloma

    11C-acetate positron emission tomography is more precise than 18F-fluorodeoxyglucose positron emission tomography in evaluating tumor burden and predicting disease risk of multiple... oleh Miao Chen, Wenjia Zhu, Jianhua Du, Chen Yang, Bing Han, Daobin Zhou, Li Huo, Junling Zhuang

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Percutaneous vertebroplasty/kyphoplasty contributes to the improved outcome in patients with newly diagnosed multiple myeloma: A single center cohort study

    Percutaneous vertebroplasty/kyphoplasty contributes to the improved outcome in patients with newly diagnosed multiple myeloma: A single center cohort study oleh Fujing Zhang, Shuzhong Liu, Xi Zhou, Wei Wang, Congwei Jia, Qin Wang, Yong Liu, Junling Zhuang

    Diterbitkan 2024-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Adding cyclosporin A to eltrombopag for aplastic anemia secondary to chemotherapy for solid cancers

    Adding cyclosporin A to eltrombopag for aplastic anemia secondary to chemotherapy for solid cancers oleh Ziqi Wan, Yang Chen, Junling Zhuang, Miao Chen, Shuyang Zhang, Bing Han, Rongman Jia, Xiuyuan Hao

    Diterbitkan 2023-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Myc rearrangement redefines the stratification of high‐risk multiple myeloma

    Myc rearrangement redefines the stratification of high‐risk multiple myeloma oleh Xianghong Jin, Hui Li, Dingding Zhang, Shuangjiao Liu, Yuhang Song, Fujing Zhang, Ziping Li, Junling Zhuang

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells.

    Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells. oleh Junling Zhuang, Jianghong Zhang, Seint T Lwin, James R Edwards, Claire M Edwards, Gregory R Mundy, Xiangli Yang

    Diterbitkan 2012-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Identifying immune checkpoints on dysregulated T-cells as prognostic biomarkers for multiple myeloma patients with COVID-19

    Identifying immune checkpoints on dysregulated T-cells as prognostic biomarkers for multiple myeloma patients with COVID-19 oleh Ziping Li, Huiwen He, Fujing Zhang, Haolong Li, Xianghong Jin, Yuhang Song, Shuangjiao Liu, Xuan Wang, Junling Zhuang

    Diterbitkan 2024-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Complete blood and urine paraprotein tests as response assessments in multiple myeloma patients treated with bortezomib, cyclophosphamide, and dexamethasone

    Complete blood and urine paraprotein tests as response assessments in multiple myeloma patients treated with bortezomib, cyclophosphamide, and dexamethasone oleh Xialu Lan, Fujing Zhang, Chen Yang, Wei Su, Jianhua Du, Shuangjiao Liu, Miao Chen, Bing Han, Daobin Zhou, Junling Zhuang

    Diterbitkan 2024-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Clinical Diagnosis and Treatment Recommendations for Immune Checkpoint Inhibitor-related Hematological Adverse Events

    Clinical Diagnosis and Treatment Recommendations for Immune Checkpoint Inhibitor-related Hematological Adverse Events oleh Junling ZHUANG, Jingting ZHAO, Xiaoxiao GUO, Jiaxin ZHOU, Lian DUAN, Wei QIU, Xiaoyan SI, Li ZHANG, Yue LI, Xiaowei LIU, Hanping WANG, Daobin ZHOU, Li ZHANG

    Diterbitkan 2019-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related hematological adverse events

    Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related hematological adverse events oleh Junling Zhuang, Jianhua Du, Xiaoxiao Guo, Jiaxin Zhou, Lian Duan, Wei Qiu, Xiaoyan Si, Li Zhang, Yue Li, Xiaowei Liu, Hanping Wang, Daobin Zhou, Li Zhang

    Diterbitkan 2020-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    P959: MAINTENANCE THERAPY FOLLOWED AUTOLOGOUS STEM CELL TRANSPLANTATION BY IXAZOMIB AND/OR LENALIDOMIDE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: A MULTICENTERED REAL WORLD STUDY IN CHINA

    P959: MAINTENANCE THERAPY FOLLOWED AUTOLOGOUS STEM CELL TRANSPLANTATION BY IXAZOMIB AND/OR LENALIDOMIDE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: A MULTICENTERED REAL WORL... oleh Minqiu Lu, Ai-Jun Liu, Wen-Ming Chen, Yin Wu, Rong Fu, Hongmei Jing, Fei Dong, Liangming MA, Weiwei Tian, Yanping MA, Bin Chu, Yutong Wang, Sun Kai, Junling Zhuang, LI Bao

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    P873: IXAZOMIB VERSUS LENALIDOMIDE OR IXAZOMIB AND LENALIDOMIDE COMBINATION AS MAINTENANCE REGIMEN FOR TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: UPDATE OF A MULTI-CENTER PROSPECTIVE STUDY IN CHINA

    P873: IXAZOMIB VERSUS LENALIDOMIDE OR IXAZOMIB AND LENALIDOMIDE COMBINATION AS MAINTENANCE REGIMEN FOR TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: UPDATE OF A MULTI-CENTER PROSPECTIVE... oleh Zhe Zhuang, Ying Tian, Lei Shi, Hong Yu, Qinhua Liu, Dongmei Zou, Weiwei Tian, Ru Feng, Fei Dong, Yanping MA, Shuangjiao Liu, Hongmei Jing, Hui Liu, Liangming MA, Wanling Sun, Rong Fu, LI Bao, Yin Wu, Wenming Chen, Junling Zhuang

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    P949: COMBINATION GA AND MPR VULNERABILITY SCORING TOOLS EFFECTIVELY IMPROVE THE ABILITY TO IDENTIFY THE FRAIL ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

    P949: COMBINATION GA AND MPR VULNERABILITY SCORING TOOLS EFFECTIVELY IMPROVE THE ABILITY TO IDENTIFY THE FRAIL ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA oleh Minqiu Lu, Liu Peng, Junling Zhuang, Mei Zhang, Zhong-Jun Xia, Zhenling LI, Hongmei Jing, Fei Dong, Wen-Ming Chen, Yin Wu, Hebing Zhou, Yu-Ping Gong, Rong Fu, Wen-Rong Huang, Bin Chu, Yutong Wang, Yong-Qing Zhang, Sun Kai, LI Bao

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Lenalidomide or bortezomib as maintenance treatment remedy the inferior impact of high-risk cytogenetic abnormalities in non-transplant patients with newly diagnosed multiple myeloma: a real-world multi-centered study in China

    Lenalidomide or bortezomib as maintenance treatment remedy the inferior impact of high-risk cytogenetic abnormalities in non-transplant patients with newly diagnosed multiple myelo... oleh Zhe Zhuang, Ying Tian, Lei Shi, Dongmei Zou, Ru Feng, Wei-wei Tian, Hong Yu, Fei Dong, Aijun Liao, Yanping Ma, Qinhua Liu, Shuangjiao Liu, Hongmei Jing, Rong Fu, Liang-ming Ma, Hui Liu, Wanling Sun, Li Bao, Yin Wu, Wenming Chen, Junling Zhuang

    Diterbitkan 2023-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Efficacy and safety of blinatumomab in Chinese adults with Ph-negative relapsed/refractory B-cell precursor acute lymphoblastic leukemia: A multicenter open-label single-arm China registrational study

    Efficacy and safety of blinatumomab in Chinese adults with Ph-negative relapsed/refractory B-cell precursor acute lymphoblastic leukemia: A multicenter open-label single-arm China... oleh Hongsheng Zhou, Qingsong Yin, Jie Jin, Ting Liu, Zhen Cai, Bin Jiang, Dengju Li, Zimin Sun, Yan Li, Yanjuan He, Liping Ma, Sujun Gao, Jianda Hu, Aili He, Xin Du, Daihong Liu, Xiaohong Zhang, Xiaoyan Ke, Junling Zhuang, Yue Han, Xiaoqin Wang, Yuqi Chen, Paul Gordon, Dong Yu, Gerhard Zugmaier, Jianxiang Wang

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    S212: A RANDOMIZED DOUBLE-BLIND PHASE 3 STUDY OF JAKTINIB VERSUS HYDROXYUREA IN PATIENTS WITH INTERMEDIATE-2 OR HIGH RISK MYELOFIBROSIS

    S212: A RANDOMIZED DOUBLE-BLIND PHASE 3 STUDY OF JAKTINIB VERSUS HYDROXYUREA IN PATIENTS WITH INTERMEDIATE-2 OR HIGH RISK MYELOFIBROSIS oleh Yi Zhang, Hu Zhou, Junling Zhuang, Aili He, Yarong LI, Linhua Yang, Xin Du, Sujun Gao, Guangsheng He, Mei Hong, Qian Jiang, Zhongxing Jiang, Sun Kai, Lingling Yue, Cuiping Zheng, Zeping Zhou, Chenghao Jin, Hongmei Jing, Lin Liu, Qingchi Liu, Jishi Wang, Wen Wu, Yajing Xu, Dengshu Wu, Na Xu, Feng Zhang, Jin Zhang, Huanling Zhu, Zhijian Xiao, Jie Jin

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Clinical Recommendations for Perioperative Immunotherapy-induced Adverse Events in Patients with Non-small Cell Lung Cancer

    Clinical Recommendations for Perioperative Immunotherapy-induced Adverse Events in Patients with Non-small Cell Lung Cancer oleh Jun NI, Miao HUANG, Li ZHANG, Nan WU, Chunxue BAI, Liang’an CHEN, Jun LIANG, Qian LIU, Jie WANG, Yilong WU, Fengchun ZHANG, Shuyang ZHANG, Chun CHEN, Jun CHEN, Wentao FANG, Shugeng GAO, Jian HU, Tao JIANG, Shanqing LI, Hecheng LI, Yongde LIAO, Yang LIU, Deruo LIU, Hongxu LIU, Jianyang LIU, Lunxu LIU, Mengzhao WANG, Changli WANG, Fan YANG, Yue YANG, Lanjun ZHANG, Xiuyi ZHI, Wenzhao ZHONG, Yuzhou GUAN, Xiaoxiao GUO, Chunxia HE, Shaolei LI, Yue LI, Naixin LIANG, Fangliang LU, Chao LV, Wei LV, Xiaoyan SI, Fengwei TAN, Hanping WANG, Jiangshan WANG, Shi YAN, Huaxia YANG, Huijuan ZHU, Junling ZHUANG, Minglei ZHUO

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: